Melanoma: Battle Of 3 Cancer Vaccines
Seeking Alpha
Amgen's And Vical's Melanoma Trials: Questions
Seeking Alpha
3 Events Biotech Investors Need to Watch in 2013
Motley Fool
Glaxo's Genital Herpes Vaccine Flops But Genocea's Next-Generation Approach Makes It A Buy
Seeking Alpha
OncoSec Medical: 2013 Will Be A Year Of Crucial Events
Seeking Alpha
Vical's Allovectin: Update On The Phase III Trial
Seeking Alpha

